Month: March 2022

Evaluating European Biotech Commercialization
March 23, 2022 Blog Post Snowfish

A recent Financial Times article highlighted an interesting disparity between the U.S and Europe: despite having roughly similar numbers of top academic life science institutions, European firms struggle to commercialize their biotech expertise. Despite European academia publishing 8% more science and engineering articles, U.S biotechs are responsible for more approved drugs and have easier access
Details

GlaxoSmithKline Spin Off: The Impact of GSK’s Divesture of Haleon
March 6, 2022 Blog Post Snowfish

GlaxoSmithKline made headlines this week with the announcement that it expects offshoot its joint consumer healthcare venture Haleon. Haleon represents a joint venture between GSK and Pfizer that owns brands such as Sensodyne, Panadol and Centrum. On Monday, GSK CEO Emma Watson announced the details of the split, citing that the spin off “promises to
Details